EP3773713
LEPTÍN-VIÐTAKAÖRVAMÓTEFNI TIL AÐ NOTA VIÐ AÐ AUKA BEINMASSA HJÁ SJÚKLINGI SEM ÞJÁIST AF EFNASKIPTARANGSTARFSEMI EÐA LEPTÍNSKORTI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.4.2019EP published:
9.7.2025EP application number:
19718562.2
EP translation filed:
13.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
4.4.2039Expiry date:
4.4.2026
Title in English:
A LEPTIN RECEPTOR AGONIST ANTIBODY FOR USE IN INCREASING BONE MASS IN A SUBJECT SUFFERING FROM METABOLIC DYSFUNCTION OR HYPOLEPTINEMIALanguage of the patent:
English
Timeline
Today
5.4.2019EP application
9.7.2025EP Publication
13.8.2025Translation submitted
15.9.2025Registration published
4.4.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
GROMADA, JesperAddress:
New York 10591, US
Name:
STEVIS, PanayiotisAddress:
New York 10591, US
Name:
ALTAREJOS, JudithAddress:
New York 10591, US
Name:
MURPHY, Andrew J.Address:
New York 10591, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862653731 PDate:
6.4.2018Country:
US
Classification
Categories:
C07K 16/28, A61P 3/00, A61P 3/04, A61P 3/14